Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.

KEY POINTS Coronavirus disease 2019 (COVID-19) is a rapidly evolving pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In addition to minimizing risk of transmission by nonpharmacologic measures, 1 or more effective vaccines would be invaluable to reduce the burden of